Phillips-Medisize A/S
CVR: 24053415
Secondary names: Medicom Innovation Partner a/s
Previous names: BANG & OLUFSEN EXPORT A/S, BANG & OLUFSEN TECHNOLOGY A/S, BANG & OLUFSEN MEDICOM A/S
The financial health of Phillips-Medisize A/S shows signs of volatility, with a notable decline in both revenue and profit from 2023 to 2024. Revenue decreased from 481.9 million DKK to 425.6 million DKK, while profit fell sharply from 83.4 million DKK to 12.1 million DKK. Despite this downturn, the company has demonstrated growth in previous years, with revenue increasing from 274.6 million DKK in 2020 to a peak of 481.9 million DKK in 2023. However, the significant drop in equity from 241.4 million DKK to 113.5 million DKK raises concerns about financial stability and operational efficiency. Positioned within the medical and dental instrument manufacturing sector, the company may need to address these challenges to maintain its competitive edge.
AI-generated summary
Overview
Details
Contact
Purpose
Selskabets formål er at forestå integreret produktudvikling og/eller produktion af medicoteknisk udstyr og hermed beslægtet virksomhed efter bestyrelsens skøn.
Location
Financials
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 425.6 mio. | 12.1 mio. | 242.3 mio. | 113.5 mio. | - | |
History
Ownership
Properties
(1)· 2 historic1 properties
Upgrade to Pro to see addresses, building data and ownership details
Management
Directors
Board
Production units (5)
Similar companies
Companies in the same industry and area